Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00996-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Valerie F A March und 10 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Tropical and Public Health Institute, Allschwil, Switzerland. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Swiss National Science Foundation.
Abstract (Originalsprache)
Drug tolerance allows bacteria to survive extended exposure to bactericidal drugs and is thought to play a role in drug resistance evolution. In Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), multidrug-resistant TB outbreaks are frequently caused by strains belonging to two phylogenetic lineages of the human-adapted strains of the Mtb complex, namely, lineages (L) 2 and L4. We hypothesized that members of L2 and L4 are more intrinsically drug tolerant and, as such, more readily evolve drug resistance. To explore this, we devised a high-throughput in vitro assay to measure drug tolerance in Mtb. We selected a cohort of strains representative of the globally most frequent lineages, L1–L4. We measured tolerance to rifampicin and bedaquiline and found L3 and L4 strains to have higher tolerance compared to L1 and L2 strains. In addition, phylogenetically closely related strains exhibited similar levels of tolerance, suggesting that tolerance is heritable. Finally, we explored genes previously reported to be associated with tolerance in Mtb and found significant enrichment in mutations in genes involved in cell wall and cell processes, intermediary metabolism and respiration, as well as lipid metabolism in high-tolerance strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
- University of Basel, Basel, Switzerland.
ORCID-Profile: Sebastien Gagneux, Sonia Borrell
Förderung
- European Research Council
- Swiss National Science Foundation
Zitieren
APA
March, V. F. A., Zwyer, M., Loiseau, C., Brites, D., Goig, G. A., Bouaouina, S., Doetsch, A., Reinhard, M., Kalkan, S., Gagneux, S., & Borrell, S. (2025). Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00996-25
Vancouver
March VFA, Zwyer M, Loiseau C, Brites D, Goig GA, Bouaouina S, et al. Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00996-25
BibTeX
@article{March2025,
author = {March, Valerie F A and Zwyer, Michaela and Loiseau, Chloé and Brites, Daniela and Goig, Galo A and Bouaouina, Selim and Doetsch, Anna and Reinhard, Miriam and Kalkan, Sevda and Gagneux, Sebastien and Borrell, Sonia},
title = {Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00996-25}
}
EUVIMED